Induction of polyploidy in adenovirus E1-transformed cells by the mitotic inhibitor colcemid

O Kranenburg1, A J Van der Eb, A Zantema

  • 1Sylvius Laboratory, Department of Molecular Carcinogenesis, Leiden University, The Netherlands.

Virus Research
|February 1, 1996
PubMed

Insights

Adenovirus-transformed cells resist cell cycle inhibitors like colcemid, continuing DNA synthesis without dividing. This leads to polyploidy, an effect requiring both E1A and E1B viral proteins.

Area of Science:

  • Cell biology
  • Virology
  • Molecular biology

Background:

  • Cell cycle regulation is crucial for normal cell function.
  • Viral oncogenes can disrupt normal cellular processes, including cell cycle control.

Purpose of the Study:

  • To investigate the DNA synthesis capabilities of adenovirus-transformed cells under cell cycle arrest.
  • To determine the resistance profile of these cells against various cell cycle inhibitory drugs.

Main Methods:

  • Adenovirus-transformed cells were treated with a panel of cell cycle inhibitors.
  • DNA synthesis was measured in treated cells.
  • Cellular ploidy was assessed after treatment with colcemid.

Main Results:

  • Transformed cells exhibited complete resistance to colcemid and partial resistance to lovastatin, mimosine, aphidicolin, and genistein.
  • Hydroxyurea and thymidine did not inhibit DNA synthesis in these cells.
  • Colcemid treatment induced high polyploidy in AdE1-transformed cells, dependent on E1A and E1B expression.

Conclusions:

  • Adenovirus E1A and E1B proteins confer resistance to specific cell cycle inhibitors, enabling continued DNA synthesis.
  • This resistance leads to polyploidization, highlighting a mechanism by which viral oncogenes disrupt cell cycle checkpoints.